Citi raised the firm’s price target on McKesson (MCK) to $670 from $620 and keeps a Buy rating on the shares. The analyst believes the Q2 reports from the healthcare distribution group are set to a “stock pickers earnings season.” The firm likes the setup for Cencora (COR) the best.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
Questions or Comments about the article? Write to editor@tipranks.com